Sec. 1115. ENFORCEMENT
159 words·~1 min read·
/statute-compilations/comps-11833/sec-1115A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
## SEC. 1115 ENFORCEMENT ###
(a)Civil Penalty Any brand name drug company , generic drug applicant, or biosimilar biological product applicant which fails to comply with any provision of this subtitle shall be liable for a civil penalty of not more than $11,000, for each day during which such entity is in violation of this subtitle. Such penalty may be recovered in a civil action brought by the United States, or brought by the Commission in accordance with the procedures established in section 16(a)(1) of the Federal Trade Commission Act (15 U.S.C. 56(a)). ###
(b)Compliance and Equitable Relief If any brand name drug company , generic drug applicant, or biosimilar biological product applicant fails to comply with any provision of this subtitle, the United States district court may order compliance, and may grant such other equitable relief as the court in its discretion determines necessary or appropriate, upon application of the Assistant Attorney General or the Commission.
Connectionstraces to 1
Traces to 1 document